Defective Epstein-Barr virus in chronic active infection and haematological malignancy.


Journal

Nature microbiology
ISSN: 2058-5276
Titre abrégé: Nat Microbiol
Pays: England
ID NLM: 101674869

Informations de publication

Date de publication:
03 2019
Historique:
received: 01 06 2018
accepted: 04 12 2018
pubmed: 22 1 2019
medline: 6 6 2019
entrez: 22 1 2019
Statut: ppublish

Résumé

Epstein-Barr virus (EBV) infection is highly prevalent in humans and is implicated in various diseases, including cancer

Identifiants

pubmed: 30664667
doi: 10.1038/s41564-018-0334-0
pii: 10.1038/s41564-018-0334-0
doi:

Substances chimiques

BRLF1 protein, Human herpesvirus 4 0
BZLF1 protein, Herpesvirus 4, Human 0
DNA-Binding Proteins 0
Immediate-Early Proteins 0
MicroRNAs 0
Trans-Activators 0
Viral Proteins 0
BALF5 protein, Epstein-barr virus EC 2.7.7.7
DNA-Directed DNA Polymerase EC 2.7.7.7

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

404-413

Commentaires et corrections

Type : ErratumIn

Auteurs

Yusuke Okuno (Y)

Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan.

Takayuki Murata (T)

Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Yoshitaka Sato (Y)

Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Hideki Muramatsu (H)

Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Yoshinori Ito (Y)

Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Takahiro Watanabe (T)

Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Tatsuya Okuno (T)

Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Norihiro Murakami (N)

Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Kenichi Yoshida (K)

Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Akihisa Sawada (A)

Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Osaka, Japan.

Masami Inoue (M)

Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Osaka, Japan.

Keisei Kawa (K)

Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Osaka, Japan.

Masao Seto (M)

Department of Pathology, Kurume University School of Medicine, Kurume, Japan.

Koichi Ohshima (K)

Department of Pathology, Kurume University School of Medicine, Kurume, Japan.

Yuichi Shiraishi (Y)

Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Kenichi Chiba (K)

Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Hiroko Tanaka (H)

Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Satoru Miyano (S)

Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Yohei Narita (Y)

Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Masahiro Yoshida (M)

Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Fumi Goshima (F)

Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Jun-Ichi Kawada (JI)

Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Tetsuya Nishida (T)

Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Hitoshi Kiyoi (H)

Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Seiichi Kato (S)

Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.

Shigeo Nakamura (S)

Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan.

Satoko Morishima (S)

Division of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan.

Tetsushi Yoshikawa (T)

Department of Pediatrics, Fujita Health University School of Medicine, Toyoake, Japan.

Shigeyoshi Fujiwara (S)

Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.

Norio Shimizu (N)

Center for Stem Cell and Regenerative Medicine, Division of Advanced Biomedical Engineering Research, Institute of Research, Tokyo Medical and Dental University, Tokyo, Japan.

Yasushi Isobe (Y)

Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.

Masaaki Noguchi (M)

Department of Hematology, Juntendo University Urayasu Hospital, Urayasu, Japan.

Atsushi Kikuta (A)

Department of Pediatric Oncology, Fukushima Medical University School of Medicine, Fukushima, Japan.

Keiji Iwatsuki (K)

Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

Yoshiyuki Takahashi (Y)

Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Seiji Kojima (S)

Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Seishi Ogawa (S)

Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Hiroshi Kimura (H)

Department of Virology, Nagoya University Graduate School of Medicine, Nagoya, Japan. hkimura@med.nagoya-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH